S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in
NYSE:ABC

AmerisourceBergen Stock Forecast, Price & News

$103.34
-0.91 (-0.87 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$103.32
Now: $103.34
$104.94
50-Day Range
$101.22
MA: $105.85
$111.92
52-Week Range
$72.06
Now: $103.34
$112.88
Volume783,227 shs
Average Volume1.29 million shs
Market Capitalization$21.15 billion
P/E RatioN/A
Dividend Yield1.69%
Beta0.57
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
AmerisourceBergen logo

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP03073E10
Phone610-727-7000
Employees22,000
Year Founded2001

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$189.89 billion
Cash Flow$9.67 per share
Book Value($4.11) per share

Profitability

Net Income$-3,408,720,000.00

Miscellaneous

Market Cap$21.15 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

2.09 out of 5 stars

Medical Sector

47th out of 1,968 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 14 stocks

Analyst Opinion: 3.4Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -
$103.34
-0.91 (-0.87 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

Is AmerisourceBergen a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last twelve months. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen
or view top-rated stocks.

What stocks does MarketBeat like better than AmerisourceBergen?

Wall Street analysts have given AmerisourceBergen a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AmerisourceBergen wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AmerisourceBergen?

AmerisourceBergen saw a decrease in short interest during the month of February. As of February 12th, there was short interest totaling 2,230,000 shares, a decrease of 18.3% from the January 28th total of 2,730,000 shares. Based on an average daily volume of 1,150,000 shares, the short-interest ratio is presently 1.9 days. Approximately 1.5% of the company's shares are sold short.
View AmerisourceBergen's Short Interest
.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for AmerisourceBergen
.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) issued its quarterly earnings results on Wednesday, February, 3rd. The company reported $2.18 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.94 by $0.24. The business had revenue of $52.50 billion for the quarter, compared to the consensus estimate of $50.49 billion. AmerisourceBergen had a negative net margin of 1.80% and a positive trailing twelve-month return on equity of 65.93%. The firm's revenue for the quarter was up 9.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.76 EPS.
View AmerisourceBergen's earnings history
.

How has AmerisourceBergen's stock price been impacted by COVID-19 (Coronavirus)?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ABC shares have increased by 21.6% and is now trading at $103.34.
View which stocks have been most impacted by COVID-19
.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Thursday, January 14th. Investors of record on Friday, February 12th will be given a dividend of $0.44 per share on Monday, March 1st. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.70%. The ex-dividend date of this dividend is Thursday, February 11th.
View AmerisourceBergen's dividend history
.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.69%. AmerisourceBergen does not yet have a strock track record of dividend growth. The dividend payout ratio of AmerisourceBergen is 22.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 18.78% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen issued an update on its FY21 earnings guidance on Thursday, February, 4th. The company provided EPS guidance of $8.40-$8.60 for the period, compared to the Thomson Reuters consensus estimate of $8.42.

What price target have analysts set for ABC?

10 brokerages have issued 12 month target prices for AmerisourceBergen's shares. Their forecasts range from $88.00 to $150.00. On average, they expect AmerisourceBergen's share price to reach $121.11 in the next twelve months. This suggests a possible upside of 17.2% from the stock's current price.
View analysts' price targets for AmerisourceBergen
or view top-rated stocks among Wall Street analysts.

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:
  • Mr. Steven H. Collis, Chairman, Pres & CEO (Age 60, Pay $4.55M) (LinkedIn Profile)
  • Mr. James F. Cleary Jr., Exec. VP & CFO (Age 58, Pay $1.78M) (LinkedIn Profile)
  • Ms. Gina K. Clark, Exec. VP and Chief Communications & Admin. Officer (Age 64, Pay $1.46M) (LinkedIn Profile)
  • Mr. John G. Chou, Exec. VP & Chief Legal Officer (Age 65, Pay $1.75M) (LinkedIn Profile)
  • Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP & Group Pres (Age 54, Pay $1.81M) (LinkedIn Profile)
  • Mr. Lazarus Krikorian, Sr. VP, Chief Accounting Officer & Corp. Controller (Age 56)
  • Bennett S. Murphy, Sr. VP of Investor Relations
  • Ms. Kathy H. Gaddes, Exec. VP & Chief Compliance Officer (Age 58)
  • Ms. Silvana Battaglia, Exec. VP & Chief HR Officer (Age 54) (LinkedIn Profile)
  • Ms. Leslie E. Donato, Exec. VP & Chief Strategy Officer (Age 52) (LinkedIn Profile)

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

Who are some of AmerisourceBergen's key competitors?

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), The Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), The Home Depot (HD) and Pfizer (PFE).

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.41%), JPMorgan Chase & Co. (3.64%), Boston Partners (2.17%), FIL Ltd (1.30%), Beutel Goodman & Co Ltd. (1.12%) and Northern Trust Corp (1.06%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, James F Cleary Jr, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Richard W Gochnauer, Robert P Mauch and Steven H Collis.
View institutional ownership trends for AmerisourceBergen
.

Which major investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., FIL Ltd, BlackRock Inc., Boston Partners, Lord Abbett & CO. LLC, Bank of New York Mellon Corp, AJO LP, and State of Wisconsin Investment Board. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Jane E Md Henney, John G Chou, Lazarus Krikorian, Robert P Mauch, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen
or view top insider-selling stocks.

Which major investors are buying AmerisourceBergen stock?

ABC stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, American International Group Inc., First Trust Advisors LP, Rothschild & Co. Asset Management US Inc., Retirement Systems of Alabama, Renaissance Technologies LLC, JPMorgan Chase & Co., and GWM Advisors LLC. Company insiders that have bought AmerisourceBergen stock in the last two years include Dermot Mark Durcan, and James F Cleary Jr.
View insider buying and selling activity for AmerisourceBergen
or or view top insider-buying stocks.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $103.34.

How much money does AmerisourceBergen make?

AmerisourceBergen has a market capitalization of $21.15 billion and generates $189.89 billion in revenue each year. The company earns $-3,408,720,000.00 in net income (profit) each year or $7.90 on an earnings per share basis.

How many employees does AmerisourceBergen have?

AmerisourceBergen employs 22,000 workers across the globe.

Does AmerisourceBergen have any subsidiaries?

The following companies are subsidiares of AmerisourceBergen: ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group AG, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Oncology Network Solutions Inc., IntrinsiQ, Lash Group, MWI Veterinary Supply, MWI Veterinary Supply Co., MWI Veterinary Supply Inc., Network for Medical Communications & Research, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, World Courier, World Courier Group S.à r.l., and Xcenda.

When was AmerisourceBergen founded?

AmerisourceBergen was founded in 2001.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

Where are AmerisourceBergen's headquarters?

AmerisourceBergen is headquartered at 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]


This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.